Implementation of an Enhanced Recovery After Surgery Protocol for Cleft Palate Repair.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 38857003.
- Also identified by DOI 10.1097/SAP.0000000000003951.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study examines an Enhanced Recovery After Surgery (ERAS) protocol for patients with cleft palate and hypothesizes that patients who followed the protocol would have decreased hospital length of stay and decreased narcotic usage than those who did not. Retrospective cohort study. The study takes place at a single tertiary children's hospital. All patients who underwent cleft palate repair during a 10-year period (n = 242). All patients underwent cleft palate repair with the most recent cohort following a new ERAS protocol. Primary outcomes included hospital length of stay and narcotic usage in the first 24 hours after surgery. Use of local bupivacaine during surgery was associated with decreased initial 24-hour morphine equivalent usage: 2.25 vs 3.38 mg morphine equivalent (MME) (P < 0.01), and a decreased hospital length of stay: 1.71 days vs 2.27 days (P < 0.01). The highest 24-hour morphine equivalent a patient consumed prior to the ERAS protocol implementation was 24.53 MME, compared with 6.3 MME after implementation. Utilization of the ERAS protocol was found to be associated with a decreased hospital length of stay: 1.67 vs 2.18 days (P < 0.01). Use of the proposed ERAS protocol may lead to lower narcotic usage and decreased length of stay.
Medical subject headings
- Cleft Palate
- Length of Stay
- Enhanced Recovery After Surgery
- Clinical Protocols